#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Congenital hypotransferrinaemia Nephroblastoma Polycystic liver disease Liposarcoma Inclusion body myositis Diffuse large B-cell lymphoma refractory Renal disorder Breast angiosarcoma metastatic Erythema multiforme Hepatic cirrhosis Familial hypertriglyceridaemia Thrombotic microangiopathy Hyperphagia Medulloblastoma Cluster headache More trials…

    Learn about Rare Diseases

    MELAS syndrome – Treatment Pemphigoid – Trials in Disease Synovial sarcoma metastatic – Treatment Skin angiosarcoma – Life with Disease Haemophilia – Life with Disease Ehlers-Danlos syndrome – Treatment Pituitary-dependent Cushing’s syndrome – Trials in Disease Choroid melanoma – Diagnostics Lymphangiosarcoma – Diagnostics Ornithine transcarbamoylase deficiency – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ltp001 Ribonucleic Acid K30 Azacitidine Mirtazapine Prednisone Dulaglutide Allo-647 ANX007 Benzyl Alcohol Lbl-007 Donepezil Hydrochloride Copper (64Cu) Chloride Warfarin Sodium UDONITRECTAG METHYLPHENIDATE Pentosan Polysulfate Sodium Zimberelimab Testosterone Undecanoate AZD4512 Noradrenaline Tartrate More therapies…

    Learn about Your Condition

    Tooth loss Laparoscopic surgery Meningioma Prodromal Alzheimer's disease Corneal dystrophy Angiosarcoma recurrent Cholangitis sclerosing Macular oedema Cerebral palsy Ischaemic stroke Breast cancer stage III Hyperkalaemia Skin papilloma Lennox-Gastaut syndrome Biliary tract disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of LY3457263 compared to placebo in adults with type 2 diabetes who are taking semaglutide or tirzepatide but have not reached their blood sugar goals

    Recruiting

    2 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Tirzepatide
    Germany Poland

  • Comparing effectiveness of topical permethrin, oral ivermectin, and their combination for treating patients with confirmed scabies infection

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acarodermatitis
    Investigated Drugs:
    • Ivermectin
    Italy

  • Long-term safety study of trospium chloride and xanomeline tartrate combination (KarXT) for treatment of manic episodes in adults with Bipolar I Disorder

    Recruiting

    3 1 1
    Investigated Drugs:
    • Trospium Chloride
    • Xanomeline Tartrate
    Bulgaria Croatia Denmark France Hungary Italy +5

  • Study of Saccharomyces boulardii CNCM I-745 to treat symptoms in adults with non-constipated Irritable Bowel Syndrome

    Recruiting

    3 1 1
    Investigated Drugs:
    • Loperamide Hydrochloride
    • Saccharomyces Boulardii Cncm I-745 Lyophilized
    Portugal Spain

  • Study of typology-based coaching and education to help patients with early hormone-positive HER2-negative breast cancer manage their treatment with ribociclib

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone receptor positive HER2 negative breast cancer
    • Breast cancer
    Investigated Drugs:
    • Ribociclib
    Germany

  • Study of hypertonic saline solution and mannitol to improve recovery in patients with traumatic brain injury and high risk of intracranial hypertension

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Craniocerebral injury
    Investigated Drugs:
    • Mannitol
    • Sodium Chloride
    France
Previous Page
1 … 137 138 139 140 141 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!